Zheng YC - Search Results

1

Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness.

Zhao LJ, Li YY, Zhang YT, Fan QQ, Ren HM, Zhang C, Mardinoglu A, Chen WC, Pang JR, Shen DD, Wang JW, Zhao LF, Zhang JY, Wang ZY, Zheng YC, Liu HM. Zhao LJ, et al. Among authors: zheng yc. EMBO Rep. 2021 Aug 4;22(8):e50922. doi: 10.15252/embr.202050922. Epub 2021 May 31. EMBO Rep. 2021. PMID: 34060205 Free PMC article.

2

Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.

Duan Y, Qin W, Suo F, Zhai X, Guan Y, Wang X, Zheng Y, Liu H. Duan Y, et al. Bioorg Med Chem. 2018 Dec 15;26(23-24):6000-6014. doi: 10.1016/j.bmc.2018.10.037. Epub 2018 Oct 29. Bioorg Med Chem. 2018. PMID: 30448189

3

USP7: Novel Drug Target in Cancer Therapy.

Wang Z, Kang W, You Y, Pang J, Ren H, Suo Z, Liu H, Zheng Y. Wang Z, et al. Front Pharmacol. 2019 Apr 30;10:427. doi: 10.3389/fphar.2019.00427. eCollection 2019. Front Pharmacol. 2019. PMID: 31114498 Free PMC article.

4

Potent and specific MTH1 inhibitors targeting gastric cancer.

Zhou W, Ma L, Yang J, Qiao H, Li L, Guo Q, Ma J, Zhao L, Wang J, Jiang G, Wan X, Adam Goscinski M, Ding L, Zheng Y, Li W, Liu H, Suo Z, Zhao W. Zhou W, et al. Cell Death Dis. 2019 Jun 4;10(6):434. doi: 10.1038/s41419-019-1665-3. Cell Death Dis. 2019. PMID: 31164636 Free PMC article.

5

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A).

Li Z, Ding L, Li Z, Wang Z, Suo F, Shen D, Zhao T, Sun X, Wang J, Liu Y, Ma L, Zhao B, Geng P, Yu B, Zheng Y, Liu H. Li Z, et al. Acta Pharm Sin B. 2019 Jul;9(4):794-808. doi: 10.1016/j.apsb.2019.01.001. Epub 2019 Jan 5. Acta Pharm Sin B. 2019. PMID: 31384539 Free PMC article.

6

Development of a mass spectrometry-based pseudotargeted metabolomics strategy to analyze hormone-stimulated gastric cancer cells.

Li J, Wang Q, Zheng Y, Zhou P, Xu X, Liu X, Zhao L, Liu H. Li J, et al. J Pharm Biomed Anal. 2020 Feb 20;180:113041. doi: 10.1016/j.jpba.2019.113041. Epub 2019 Dec 10. J Pharm Biomed Anal. 2020. PMID: 31855724

7

Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation.

Sun J, Shen D, Gao Y, Zheng Y, Zhao L, Maa M, Liu H, Chen X. Sun J, et al. Onco Targets Ther. 2020 Aug 11;13:7973-7984. doi: 10.2147/OTT.S264108. eCollection 2020. Onco Targets Ther. 2020. PMID: 32848421 Free PMC article.

8

Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.

Dai XJ, Liu Y, Xiong XP, Xue LP, Zheng YC, Liu HM. Dai XJ, et al. Among authors: zheng yc. J Med Chem. 2020 Dec 10;63(23):14197-14215. doi: 10.1021/acs.jmedchem.0c00919. Epub 2020 Sep 30. J Med Chem. 2020. PMID: 32931269 Review.

9

Correction: Potent and specific MTH1 inhibitors targeting gastric cancer.

Zhou W, Ma L, Yang J, Qiao H, Li L, Guo Q, Ma J, Zhao L, Wang J, Jiang G, Wan X, Goscinski MA, Ding L, Zheng Y, Li W, Liu H, Suo Z, Zhao W. Zhou W, et al. Cell Death Dis. 2020 Oct 16;11(10):868. doi: 10.1038/s41419-020-03010-x. Cell Death Dis. 2020. PMID: 33067425 Free PMC article.

10

Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors.

Ma L, Wang H, You Y, Ma C, Liu Y, Yang F, Zheng Y, Liu H. Ma L, et al. Acta Pharm Sin B. 2020 Sep;10(9):1658-1668. doi: 10.1016/j.apsb.2020.02.006. Epub 2020 Feb 24. Acta Pharm Sin B. 2020. PMID: 33088686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page